News & Media
Menarini Group’s Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA) for the Treatment of ER+/HER2- Advanced or Metastatic Breast Cancer
Published on August 19, 2022
Gurnet Point Capital and Patient Square Capital Complete Their Acquisition of Radius Health, Inc.
Published on August 15, 2022
Radius Health Announces Agreement to be Acquired by Gurnet Point Capital and Patient Square Capital
Published on July 23, 2022